PROSTAG OTH LIPID M - PROSTAGLANDINS & OTHER LIPID MEDIATORS

Publications

  1. 2017
  2. TGFβ/SMAD signalling modulates MLL and MLL-AF4 mediated 5-lipoxygenase promoter activation

    Saul, M. J., Groher, F., Hegewald, A. B., Müller-McNicoll, M., Marschalek, R., Suess, B. & Steinhilber, D., 11.2017, In: PROSTAG OTH LIPID M. 133, p. 60-67 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2013
  4. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans

    Galano, J-M., Mas, E., Barden, A., Mori, T. A., Signorini, C., De Felice, C., Barrett, A., Opere, C., Pinot, E., Schwedhelm, E., Benndorf, R., Roy, J., Le Guennec, J-Y., Oger, C. & Durand, T., 01.12.2013, In: PROSTAG OTH LIPID M. 107, p. 95-102 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review